Does frailty screening reduce chronic pain scores in patients after cardiac surgery? A pilot feasibility study
Published
July 14, 2024
Paper ID
PAP-000291
Status
Published
DOI
10.65712/tmj.test000549
Advance Services
Abstract
Background: chronic pain scores remains a leading cause of avoidable harm among patients after cardiac surgery. Methods: Eligible participants were patients after cardiac surgery. Results: The adjusted odds ratio was 0.60 (95% CI 0.35 to 0.77). chronic pain scores occurred in 16% of the intervention group versus 31% of controls. Conclusion: These findings suggest that frailty screening is associated with better chronic pain scores in patients after cardiac surgery.
Introduction
Practice around frailty screening varies widely between centres. chronic pain scores remains a leading cause of avoidable harm among patients after cardiac surgery.
Guidelines make only a weak recommendation on frailty screening. chronic pain scores remains a leading cause of avoidable harm among patients after cardiac surgery.
Guidelines make only a weak recommendation on frailty screening.
The cost of chronic pain scores to health systems is substantial. Earlier studies of frailty screening were small or single-centre. Practice around frailty screening varies widely between centres.
Materials and Methods
The primary outcome was chronic pain scores, assessed blind to allocation. We conducted a pilot feasibility study across 8 centres between 2015 and 2025. Analyses were adjusted for age, sex and baseline severity. We conducted a pilot feasibility study across 14 centres between 2018 and 2024.
Missing data were handled with multiple imputation.
We conducted a pilot feasibility study across 12 centres between 2014 and 2022. Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. We conducted a pilot feasibility study across 9 centres between 2016 and 2022.
The primary outcome was chronic pain scores, assessed blind to allocation. Missing data were handled with multiple imputation.
Results
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.60 (95% CI 0.41 to 0.88).
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 2766 participants were included (median age 69 years).
The adjusted odds ratio was 0.71 (95% CI 0.36 to 0.89). Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Age < 65 | 372 | 88 | 4.8 |
| Intervention | 392 | 62 | 38.6 |
| Control | 55 | 102 | 4.2 |
| Intervention | 315 | 78 | 19.3 |
| Centre B | 721 | 73 | 28.1 |
| Female | 405 | 105 | 35.5 |
| Male | 783 | 38 | 14.7 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 3290 participants were included (median age 28 years).
Discussion
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.
Strengths include the sample size and blinded outcome assessment. Future work should test frailty screening in a pragmatic multicentre trial.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Conclusions
Frailty screening should be considered for patients after cardiac surgery to improve chronic pain scores.
References
1. Osei I, Silva D, et al. Vitamin D supplementation and time to diagnosis. BMC Med. 2023;280(7):343-1785.
2. Ahmed T, Herrera J, et al. SGLT2 inhibitors and surgical site infection. Eur Heart J. 2016;240(11):232-1775.
3. Patel U, Andersen Z, et al. Machine-learning triage and chronic pain scores. N Engl J Med. 2016;112(6):26-1682.
4. Nasser A, Rahman L, et al. A sepsis alert system and medication adherence. BMC Med. 2009;378(8):256-1726.
5. Herrera C, Haddad O, et al. Frailty screening and health-related quality of life. JAMA. 2025;303(9):467-943.
6. Osei Q, Yilmaz B, et al. Pharmacist-led medication review and glycaemic control. Lancet. 2016;47(11):453-1402.
7. Osei F, Kaur U, et al. Vitamin D supplementation and emergency department revisits. Eur Heart J. 2021;220(5):276-1181.
Appendices
Supplementary tables are available on request.